Yes you're correct 10% of TAM ex China is what they're initial estimating TAM for Zilosoul.
As previously posted below is a back of the envelop calc for 1% of TAM:
Notes:
- If price for Zilsoul becomes US$6,500 share price = $63
- EV/Revenue multiple of 15 likely to be very conservative given duration and reoccurring treatment protocol (compound effect)
- Humira achieved +65% of market share in RA
- China by itself could increase TAM by >20%
Chart, page-3526
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.030(14.6%) |
Mkt cap ! $77.92M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 24.0¢ | 21.0¢ | $368.5K | 1.617M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 36523 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 21378 | 3 |
View Market Depth
| Last trade - 11.59am 17/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |